文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

具有功能化聚乙二醇脂质的可电离脂质纳米颗粒可增加在肿瘤微环境中的滞留时间。

Ionizable lipid nanoparticles with functionalized PEG-lipids increase retention in the tumor microenvironment.

作者信息

Jester Matthew, Haley Rebecca M, Billingsley Margaret M, Figueroa-Espada Christian, Joseph Ryann A, Han Xuexiang, Mitchell Michael J

机构信息

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.

Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Mol Ther Methods Clin Dev. 2025 Mar 27;33(2):101457. doi: 10.1016/j.omtm.2025.101457. eCollection 2025 Jun 12.


DOI:10.1016/j.omtm.2025.101457
PMID:40321415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049828/
Abstract

This study explores the efficacy of ionizable lipid nanoparticles (LNPs) modified with various functionalized polyethylene glycol (PEG)-lipids for retention within the tumor microenvironment after intratumoral (IT) injection. LNPs were synthesized and characterized with four different functionalized PEG-lipids, and the top performing lipids were evaluated under formulation conditions that varied the ratio of non-modified to functionalized PEG within the LNP. These LNPs were evaluated for size, polydispersity index, zeta potential, pKa, and mRNA encapsulation efficiency, with subsequent analysis of transfection and association efficiency to HepG2 liver cancer cells. Results demonstrated that LNPs formulated with PEG-folate and PEG-maleimide showed increased association to and interaction with cancer cells, compared with the base LNP formulation, which contained only non-functionalized lipid-PEG. studies showed increased retention of surface functionalized LNPs after IT injection in a xenograft model of hepatoblastoma. By slightly modifying LNPs in this manner, it is possible to develop delivery platforms that are better suited for local intratumoral administration. Ultimately, this research underscores the potential of LNPs as a vehicle for localized cancer therapy and emphasizes the need for future investigation into the long-term retention and therapeutic efficacy of LNP formulations.

摘要

本研究探讨了用各种功能化聚乙二醇(PEG)-脂质修饰的可电离脂质纳米颗粒(LNP)在瘤内(IT)注射后在肿瘤微环境中的保留效果。合成了LNP并用四种不同的功能化PEG-脂质对其进行了表征,并在改变LNP中非修饰PEG与功能化PEG比例的制剂条件下评估了表现最佳的脂质。对这些LNP进行了粒径、多分散指数、zeta电位、pKa和mRNA包封效率的评估,随后分析了其对肝癌细胞HepG2的转染和结合效率。结果表明,与仅含有非功能化脂质-PEG的基础LNP制剂相比,用PEG-叶酸和PEG-马来酰亚胺配制的LNP显示出与癌细胞的结合和相互作用增加。研究表明,在肝母细胞瘤异种移植模型中进行IT注射后,表面功能化LNP的保留增加。通过以这种方式对LNP进行轻微修饰,有可能开发出更适合局部瘤内给药的递送平台。最终,本研究强调了LNP作为局部癌症治疗载体的潜力,并强调了未来对LNP制剂的长期保留和治疗效果进行研究的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/d5659c195529/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/202e34a39d33/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/4855527ce4ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/5bc65880f924/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/1cdfdf25113c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/591d2c980221/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/d5659c195529/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/202e34a39d33/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/4855527ce4ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/5bc65880f924/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/1cdfdf25113c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/591d2c980221/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0e/12049828/d5659c195529/gr5.jpg

相似文献

[1]
Ionizable lipid nanoparticles with functionalized PEG-lipids increase retention in the tumor microenvironment.

Mol Ther Methods Clin Dev. 2025-3-27

[2]
Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective.

J Control Release. 2025-1-10

[3]
Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines.

J Control Release. 2025-4-10

[4]
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.

Biomater Sci. 2023-6-13

[5]
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy.

Pharmaceutics. 2023-8-1

[6]
Formulation of lipid nanoparticles containing ginsenoside Rg2 and protopanaxadiol for highly efficient delivery of mRNA.

Biomater Sci. 2024-12-3

[7]
A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2.

Pharmaceutics. 2025-3-29

[8]
Optimizing lipid nanoparticles for fetal gene delivery in vitro, ex vivo, and aided with machine learning.

J Control Release. 2024-12

[9]
Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.

Curr Pharm Biotechnol. 2023-4-3

[10]
Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.

Mol Pharm. 2023-12-4

本文引用的文献

[1]
Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions.

Radiology. 2024-7

[2]
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy.

Adv Mater. 2024-6

[3]
Cancer statistics, 2024.

CA Cancer J Clin. 2024

[4]
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.

Small. 2024-3

[5]
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.

NPJ Vaccines. 2023-10-11

[6]
Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors.

Oncol Rev. 2023-8-30

[7]
Strategies for targeted gene delivery using lipid nanoparticles and cell-derived nanovesicles.

Nanoscale Adv. 2023-7-7

[8]
Thiol-Mediated Uptake of a Cysteine-Containing Nanobody for Anticancer Drug Delivery.

ACS Cent Sci. 2023-5-11

[9]
Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery.

ACS Nanosci Au. 2023-3-30

[10]
Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes.

Biomaterials. 2023-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索